Consumer Sentiment Plunges to Record Low in May Amid Iran Conflict and Inflation Fears US Retail Sales Stagnate in December Missing Growth Expectations Diving Equipment Safety Under Scrutiny After Italian Divers Fatal Cave Incident Bond Bull Market May Pause but Rally Far From Over Expert Suggests Lenovo Shares Surge Over 15 After Record Earnings as AI Revenue Nearly Doubles Hybrid Village Stores An Innovative Retail Model Addressing Rural Germanys SocioEconomic Challenges GOOGL Q1 2026 Earnings EPS Misses Estimates as Revenue Uncertainty Weighs on Sentiment Solid Power Q1 2026 Earnings EPS Beat Drives 3 Stock Uplift Amid PreRevenue Phase GXAI Q1 2026 Earnings EPS Misses Estimates by 1765 Stock Declines Viking Holdings VIK Q1 2026 Earnings NarrowerthanExpected Loss Surprises Market Addentax Group Corp ATXG Q1 2025 Earnings Net Loss Deepens Amid Low Trading Volume MPLT Q1 2026 Earnings WiderThanExpected Loss and Stock Decline Amid ClinicalStage Pipeline Development Vertex Inc VERX Rallies 2 as Stock Approaches Key Resistance Zone JIADE LIMITED JDZG Faces Sharp Decline Key Levels to Watch Lotus Technology LOT Slips 074 as Stock Hovers Near Support Key Levels in Focus NeoGenomics Inc NEO Edges Higher as Stock Hovers Near Support in a Consolidative Phase Kenon Holdings KEN Retreats 285 Support Levels in Focus After Pullback Microsofts GitHub Faces New AI Coding Competition Amid Service Disruptions MOMO Q4 2025 Earnings EPS Misses Estimates by 4529 as Stock Rises 151 Algoma Steel Group ASTL Holds Steady at 473 as Traders Eye Key Resistance and Support Levels Market Update ZBH BUD and VTRS Show Mixed Trends Amid Sector Rotation Tax Implications of NPS Tier II Equity Fund Withdrawals LongTerm vs ShortTerm Capital Gains US Arms Sales to Taiwan Temporarily Paused Amid Iran Operations Acting Navy Secretary Indicates RVNL Shares Fall as Q4 Profit Declines 43 YearonYear JK Tyre Q4 Net Profit Surges 80 to Rs 178 Crore Announces Rs 4980 Crore Expansion Plan Microsoft and Anthropic Reportedly in Talks for AI Chip Deal Following 5 Billion Investment Canaccord Lowers Regeneron Price Target After Disappointing Phase 3 Trial Outcome